Home > Insider Trading > Filing (0001209191-17-033686)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
742112	Invacare Corp	IVC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	952680965

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314132	C Dale Laporte	One Invacare Way Elyria OH 44035		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2017-05-16	2,737	$14.95	32,585	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	20,000	Indirect	By Trust

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Stock Option (Right to Buy)	$0.00			7,858	7,858	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	7,858	7,858	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of covering tax obligations arising in connection with the vesting of restricted shares and restricted stock units.
Includes 4,254 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. These restricted stock units vest in full on May 15, 2018 after a three-year "cliff" vesting period.
Owned by the Reporting Person's Rollover IRA.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 7,858 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on February 12, 2009, at an exercise price of $19.09 per share, will expire on February 12, 2019, and became exercisable between March 31, 2010 and March 31, 2013.